companies
>
G
> Genzyme
Genzyme Corporation
Sanofi-Aventis extends Genzyme offer, terms unchanged
13 December 2010
Genzyme to sell diagnostics business to Japan’s Sekisui Chemical for $265 million
18 November 2010
Genzyme to sell genetic testing business to LabCorp for $925 million
13 September 2010
Sanofi Aventis reportedly raises offer to $71 per share
09 September 2010
Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer
31 August 2010
Sanofi-Aventis reveals $18.5-billion offer for Genzyme
30 August 2010
Genzyme begins takeover talks with Sanofi-Aventis
03 August 2010
Glaxo follows Sanofi-Aventis to biotech major Genzyme
26 July 2010
Sanofi-Aventis targets troubled Genzyme Corp for takeover
24 July 2010
Genzyme starts shipments of drugs for two rare disorders
02 December 2009
Genzyme confident of restarting virus-hit Allston plant by August
26 June 2009
Genzyme Corp shuts key facility to clean plant contamination
17 June 2009
Bayer HealthCare and Genzyme finalise strategic alliance agreement
02 June 2009
Bayer sells 3 cancer drugs to Genzyme for $650 million
01 April 2009
Genzyme and Isis announce strategic alliance including exclusive worldwide license of Mipomersen
08 January 2008
Genzyme announces FDA approval of Thyrogen for thyroid cancer ablation
18 December 2007
Genzyme nets 22 per cent stake in Bioenvision
14 July 2007
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
11 August 2004
search domain-b
go
Legal Policy | Copyright
©
1999-2010 The Information Company Private Limited. All rights reserved.
